Dr. Gina Ogilvie is a globally recognized leader in the field of women's reproductive and sexual health, with a particular expertise in cervical cancer. Her team's research has shaped global policy as the world strives to eliminate cervical cancer, including guiding policies on HPV vaccine dosing and optimal screening approaches for cervical cancer. She is a Tier 1 Canada Research Chair in Global Control of HPV related cancers, and has received global recognition for her work and contributions, including YWCA Women of Distinction (2018) and American STD Association Achievement Award (2020).